ArticleApplied health economics and health policy2016
Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
Article in Applied health economics and health policy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Consideration of intersectoral costs and benefits in health economic evaluations of pneumococcal conjugate vaccines: a systematic review.International journal of technology assessment in health care · 2026Pooled it
- Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.PLoS medicine · 2024Pooled it
- Global economic evaluation of oral cholera vaccine: A systematic review.Human vaccines & immunotherapeutics · 2018Pooled it
- Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework.PharmacoEconomics · 2018Pooled it
- A systematic review of health economic evaluations of vaccines in Brazil.Human vaccines & immunotherapeutics · 2017Pooled it
- Analysis of insecticide-treated bednet market dynamics between 2004-2021 and monetary value of additional bednet longevity.Cost effectiveness and resource allocation : C/E · 2026Article
- Economic Evaluation Methodologies of Remote Patient Monitoring for Chronic Conditions: Scoping Review.Journal of medical Internet research · 2025Article
- New Vaccine Platforms-Novel Dimensions of Economic and Societal Value and Their Measurement.Vaccines · 2024Article
- Article
- The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making.BMC medicine · 2023Article
- The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study.Vaccines · 2023Article
- Cost-effectiveness analysis of vaccination against COVID-19 in China.Frontiers in public health · 2023Article
- Acceptance and application of a broad population health perspective when evaluating vaccine.Vaccine · 2022Article
- A visual approach to the economic evaluation of vaccines: opening the health economic black box.Expert review of pharmacoeconomics & outcomes research · 2021Article
- Realising the broader value of vaccines in the UK.Vaccine: X · 2021Article
- How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future.Journal of market access & health policy · 2020Review
- From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain.PloS one · 2020Article
- Article
- MCDA from a health economics perspective: opportunities and pitfalls of extending economic evaluation to incorporate broader outcomes.Cost effectiveness and resource allocation : C/E · 2018Article
- Estimating the full public health value of vaccination.Vaccine · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Economic evaluation of vaccination is a key tool to inform effective spending on vaccines. However, many evaluations have been criticised for failing to capture features of vaccines which are relevant to decision makers. These include broader societal benefits (such as improved educational achievement, economic growth and political stability), reduced health disparities, medical innovation, reduced hospital beds pressures, greater peace of mind and synergies in economic benefits with non-vaccine interventions. Also, the fiscal implications of vaccination programmes are not always made explicit. Alternative methodological frameworks have been proposed to better capture these benefits. However, any broadening of the methodology for economic evaluation must also involve evaluations of non-vaccine interventions, and hence may not always benefit vaccines given a fixed health-care budget. The scope of an economic evaluation must consider the budget from which vaccines are funded, and the decision-maker's stated aims for that spending to achieve.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.